HLS Therapeutics Inc. - HLTRF

Detailed investor-level table based on 13F positions.

Shareholders (13F)

Quarter: Q1 2023
13D/13G major owners: Ownership tab.
Methodology: Market value and % of portfolio use SEC reported VALUE ($000). For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received. Details.
Rows: 0
Investor History Status Shares held Market value ($000) % of portfolio Previous % Rank Change in shares % change in shares Source Date reported
Canoe Financial LP History New 499,001 2,326 0.03% 1 +499,001 New Q1 2023 Apr 27, 2023